Skip to main content
OpenTrials
Completed

NCT Number: NCT01417117

Effect of Ischemic Strokes on Recovery From Intracerebral Hemorrhages

Intracerebral hemorrhage (ICH) occurs when small arteries in the brain rupture due to weakening by age, high blood pressure, and/or elevated cholesterol. In addition to artery rupture, recent data suggests that patients with ICH are also at risk for developing occlusion of arteries during the acute phase, called ischemic strokes. Data suggests these ischemic strokes can negatively impact patient outcomes. Diffusion weighted imaging (DWI) is a sequence on Magnetic Resonance Imaging (MRI) that is a sensitive marker for ischemic strokes in the brain. In this proposal, our primary aim is examine prospectively the effect DWI abnormalities have on functional outcomes in patients with ICH. Our hypothesis is that the DWI abnormalities found on MRI of the brain lead to worse functional outcomes in patients with ICH

Completed

Looking for future studies?

Notify Me

Key information

About this study

Diffusion weighted imaging (DWI) is a sensitive method to assess for secondary ischemia in patients with acute brain injury. By comparing the outcomes of patients with and without DWI abnormalities, we would able to assess the impact these lesions have on functional recovery in patients with ICH. Since no direct therapies exist for this disease, DWI abnormalities may be a novel target for intervention to improve outcomes. If traditionally assessed functional outcomes are not affected by DWI, the mechanism behind these lesions would still warrant further evaluation and potential treatment. Detection of subclinical infarcts has emerged as a potential surrogate marker for subsequent risk of stroke, vascular dementia, and cognitive impairment. Furthermore, the cause behind DWI lesions in acute ICH may lead to better understanding the pathophysiologic interplay between ischemic and hemorrhagic strokes.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients > 18 years and < 80 years
  • Spontaneous intracerebral hemorrhage documented by CT scan
  • Less than 24 hours from time last seen normal to first medical evaluation
  • No prior clinical history of stroke (i.e. subarachnoid hemorrhage, ICH, or ischemic strokes)

Exclusion criteria

  • Pregnancy
  • History of cancer
  • Pre-admission mRS > 2
  • Glasgow Coma Scale less than 5
  • ICH secondary to aneurysm, vascular malformation, mycotic aneurysm, primary or metastatic tumor, trauma, warfarin-related ICH, acute-fibrinolytic associated ICH, or coagulopathy
  • Associated epidural or subdural hematoma
  • Surgical intervention < 48 hours from admission
  • Hemodynamic instability (need for vasopressor therapy)
  • Acute hypoxemic or hypercapnic respiratory failure
  • History of deep venous thrombosis
  • Contraindications to MRI based upon institutional safety checklist

Treatment and study plan

Primary outcomes

  1. Modified Rankin Scale (mRS)

    Time frame: 3 months

    Modified Rankin Scale (mRS)

Secondary outcomes

  1. National Institutes of Health Stroke Scale

    Time frame: 14 days or discharge

    National Institutes of Health Stroke Scale

  2. Modified Rankin Scale (mRS)

    Time frame: 14 days

    Modified Rankin Scale (mRS)

  3. Modified Rankin Scale (mRS)

    Time frame: 6 months

    Modified Rankin Scale (mRS)

Sponsors and collaborators

Lead sponsor

Rush University Medical Center

Other

Collaborators

  • American Heart Association
  • Rush University

Registry information

Official study title

The Effect of Diffusion Weighted Imaging Abnormalities on Outcomes in Patients With Spontaneous Intracerebral Hemorrhage

Important dates

Study start
2011
Primary completion
2017
Study completion
2017
First posted
Aug 16, 2011
Registry last updated
Oct 20, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.